Review Article| Volume 355, ISSUE 1, P6-12, January 2018

Topical Treatment of Degenerative Knee Osteoarthritis


      This article reviews topical management strategies for degenerative osteoarthritis (OA) of the knee. A search of Pubmed, Embase and the Cochrane library using MeSH terms including “topical,” “treatment,” “knee” and “osteoarthritis” was carried out. Original research and review articles on the effectiveness and safety, recommendations from international published guidelines and acceptability studies of topical preparations were included. Current topical treatments included for the management of knee OA include topical nonsteroidal anti-inflammatory drugs, capsaicin, salicylates and physical treatments such as hot or cold therapy. Current treatment guidelines recommend topical nonsteroidal anti-inflammatory drugs as an alternative and even first-line therapy for OA management, especially among elderly patients. Guidelines on other topical treatments vary, from recommendations against their use, to in favor as alternative or simultaneous therapy, especially for patients with contraindications to other analgesics. Although often well-tolerated and preferred by many patients, clinical care still lags in the adoption of topical treatments. Aspects of efficacy, safety and patient quality of life data require further research.

      Key Indexing Terms

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Brooks P.M.
        Impact of osteoarthritis on individuals and society: how much disability? Social consequences and health economic implications.
        Curr Opin Rheumatol. 2002; 14: 573-577
        • Johnson V.L.
        • Hunter D.J.
        The epidemiology of osteoarthritis.
        Best Pract Res Clin Rheumatol. 2014; 28: 5-15
        • Oliveria S.A.
        • Felson D.T.
        • Reed J.I.
        • et al.
        Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization.
        Arthritis Rheum. 1995; 38: 1134-1141
        • Philbin E.F.
        • Groff G.D.
        • Ries M.D.
        • et al.
        Cardiovascular fitness and health in patients with end-stage osteoarthritis.
        Arthritis Rheum. 1995; 38: 799-805
        • Guccione A.A.
        • Felson D.T.
        • Anderson J.J.
        • et al.
        The effects of specific medical conditions on the functional limitations of elders in the Framingham Study.
        Am J Public Health. 1994; 84: 351-358
        • Hartvigsen J.
        • Davidsen M.
        • Søgaard K.
        • et al.
        Self-reported musculoskeletal pain predicts long-term increase in general health care use: a population-based cohort study with 20-year follow-up.
        Scand J Public Health. 2014; 42: 698-704
        • McKenna M.T.
        • Michaud C.M.
        • Murray C.J.L.
        • et al.
        Assessing the burden of disease in the United States using disability-adjusted life years.
        Am J Prev Med. 2005; 28: 415-423
      1. American Academy of Orthopaedic Surgeons. Treatment of osteoarthritis (OA) of the knee (non-arthroplasty)—2nd ed. 2013; Available from:

        • Roth S.
        • Fuller P.
        Pooled safety analysis of diclofenac sodium topical solution 1.5% (w/w) in the treatment of osteoarthritis in patients aged 75 years or older.
        Clin Interv Aging. 2012; 7: 127-137
        • Altman R.D.
        • Barthel H.R.
        Topical therapies for osteoarthritis.
        Drugs. 2011; 71: 1259
        • Schilling A.
        • Corey R.
        • Leonard M.
        • et al.
        Acetaminophen: old drug, new warnings.
        Cleve Clin J Med. 2010; 77: 19-27
        • Boers M.
        • Tangelder M.J.D.
        • van Ingen H.
        • et al.
        The rate of NSAID-induced endoscopic ulcers increases linearly but not exponentially with age: a pooled analysis of 12 randomised trials.
        Ann Rheum Dis. 2007; 66: 417-418
        • Antman E.M.
        • Bennett J.S.
        • Daugherty A.
        • et al.
        Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association.
        Circulation. 2007; 115: 1634-1642
        • Farkouh M.E.
        • Greenberg B.P.
        An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs.
        Am J Cardiol. 2009; 103: 1227-1237
        • Huerta C.
        • Castellsague J.
        • Varas-Lorenzo C.
        • et al.
        Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population.
        Am J Kidney Dis. 2005; 45: 531-539
        • Schmeltzer P.A.
        • Kosinski A.S.
        • Kleiner D.E.
        • et al.
        Liver injury from nonsteroidal anti-inflammatory drugs in the United States.
        Liver Int. 2016; 36: 603-609
        • Bozimowski G.
        A review of nonsteroidal anti-inflammatory drugs.
        AANA J. 2015; 83: 425-433
        • Laslett L.L.
        • Jones G.
        Capsaicin for osteoarthritis pain.
        Prog Drug Res. 2014; 68: 277-291
        • Nolano M.
        • Simone D.A.
        • Wendelschafer-Crabb G.
        • et al.
        Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation.
        Pain. 1999; 81: 135-145
        • Kim C.-S.
        • Kawada T.
        • Kim B.-S.
        • et al.
        Capsaicin exhibits anti-inflammatory property by inhibiting IkB-a degradation in LPS-stimulated peritoneal macrophages.
        Cell Signal. 2003; 15: 299-306
        • Flynn D.L.
        • Rafferty M.F.
        • Boctor A.M.
        Inhibition of human neutrophil 5-lipoxygenase activity by gingerdione, shogaol, capsaicin and related pungent compounds.
        Prostaglandins Leukot Med. 1986; 24: 195-198
        • McPherson M.L.
        • Cimino N.M.
        Topical NSAID Formulations.
        Pain Med. 2013; 14: S35-S39
        • Barthel H.R.
        • Haselwood D.
        • Longley III, S.
        • et al.
        Randomized controlled trial of diclofenac sodium gel in knee osteoarthritis.
        Semin Arthritis Rheum. 2009; 39: 203-212
        • Mason L.
        • Moore R.A.
        • Edwards J.E.
        • et al.
        Systematic review of efficacy of topical rubefacients containing salicylates for the treatment of acute and chronic pain.
        Br Med J. 2004; 328: 995
        • Derry S.
        • Matthews P.R.L.
        • Wiffen P.J.
        • et al.
        Salicylate-containing rubefacients for acute and chronic musculoskeletal pain in adults.
        Cochrane Database Syst Rev. 2014; 11: CD007403
      2. Arthritis Foundation. Conditions and treatments. Disease Centre. Osteoarthritis; 2003.

        • Loeser R.F.
        • Goldring S.R.
        • Scanzello C.R.
        • et al.
        Osteoarthritis: a disease of the joint as an organ.
        Arthritis Rheum. 2012; 64: 1697-1707
        • Dawson J.
        • Linsell L.
        • Zondervan K.
        • et al.
        Epidemiology of hip and knee pain and its impact on overall health status in older adults.
        Rheumatol Oxf Engl. 2004; 43: 497-504
        • Blagojevic M.
        • Jinks C.
        • Jeffery A.
        • et al.
        Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis.
        Osteoarthritis Cartilage. 2010; 18: 24-33
        • Kellgren J.H.
        • Lawrence J.S.
        Radiological assessment of osteo-arthrosis.
        Ann Rheum Dis. 1957; 16: 494-502
        • Yucesoy B.
        • Charles L.E.
        • Baker B.
        • et al.
        Occupational and genetic risk factors for osteoarthritis: a review.
        Work Read Mass. 2015; 50: 261-273
        • Losina E.
        • Weinstein A.M.
        • Reichmann W.M.
        • et al.
        Lifetime risk and age at diagnosis of symptomatic knee osteoarthritis in the US.
        Arthritis Care Res. 2013; 65: 703-711
        • Derry S.
        • Moore R.A.
        • Rabbie R.
        Topical NSAIDs for chronic musculoskeletal pain in adults.
        Cochrane Database Syst Rev. 2016; 4: CD007400
        • Jorge L.L.
        • Feres C.C.
        • Teles V.E.
        Topical preparations for pain relief: efficacy and patient adherence.
        J Pain Res. 2011; 4: 11-24
        • Fernandes L.
        • Hagen K.B.
        • Bijlsma J.W.J.
        • et al.
        EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis.
        Ann Rheum Dis. 2013; 72: 1125-1135
        • Jordan K.M.
        • Arden N.K.
        • Doherty M.
        • et al.
        EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT).
        Ann Rheum Dis. 2003; 62: 1145-1155
        • McAlindon T.E.
        • Bannuru R.R.
        • Sullivan M.C.
        • et al.
        OARSI guidelines for the non-surgical management of knee osteoarthritis.
        Osteoarthritis Cartilage. 2014; 22: 363-388
      3. National Institute for Health and Clinical Excellence. Osteoarthritis: care and management—Guidance and guidelines—NICE [Internet]; 2014. Available from: Cited January 12, 2017.

        • American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons
        Pharmacological management of persistent pain in older persons.
        J Am Geriatr Soc. 2009; 57: 1331-1346
        • Hochberg M.C.
        • Altman R.D.
        • April K.T.
        • et al.
        American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee.
        Arthritis Care Res. 2012; 64: 465-474
        • Klinge S.A.
        • Sawyer G.A.
        Effectiveness and safety of topical versus oral nonsteroidal anti-inflammatory drugs: a comprehensive review.
        Phys Sportsmed. 2013; 41: 64-74
        • Brühlmann P.
        • de Vathaire F.
        • Dreiser R.L.
        • et al.
        Short-term treatment with topical diclofenac epolamine plaster in patients with symptomatic knee osteoarthritis: pooled analysis of two randomised clinical studies.
        Curr Med Res Opin. 2006; 22: 2429-2438
        • American College of Medical Toxicology
        Guidance document: management priorities in salicylate toxicity.
        J Med Toxicol. 2015; 11: 149-152
        • Rakovchik E.E.
        • Fein D.M.
        Nonsteroidal anti-inflammatory drug and salicylate poisoning.
        Pediatr Rev. 2016; 37: 48-50
        • Kosuwon W.
        • Sirichatiwapee W.
        • Wisanuyotin T.
        • et al.
        Efficacy of symptomatic control of knee osteoarthritis with 0.0125% of capsaicin versus placebo.
        J Med Assoc Thai. 2010; 93: 1188-1195
        • Schnitzer T.J.
        • Pelletier J.-P.
        • Haselwood D.M.
        • et al.
        Civamide cream 0.075% in patients with osteoarthritis of the knee: a 12-week randomized controlled clinical trial with a longterm extension.
        J Rheumatol. 2012; 39: 610-620
        • Silva V.D.
        • El-Metwally A.
        • Ernst E.
        • et al.
        Evidence for the efficacy of complementary and alternative medicines in the management of osteoarthritis: a systematic review.
        Rheumatology. 2011; 50: 911-920
        • Cameron M.
        • Chrubasik S.
        Topical herbal therapies for treating osteoarthritis.
        Cochrane Database Syst Rev. 2013; 5: CD010538
        • Brosseau L.
        • Yonge K.
        • Welch V.
        • et al.
        Thermotherapy for treatment of osteoarthritis.
        Cochrane Database Syst Rev. 2003; 4 ([Article no. CD004522])
        • Denegar C.
        • Dougherty D.
        • Friedman J.
        • et al.
        Preferences for heat, cold, or contrast in patients with knee osteoarthritis affect treatment response.
        Clin Interv Aging. 2010; 5: 199-206
        • Bruyère O.
        • Cooper C.
        • Pelletier J.-P.
        • et al.
        An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
        Semin Arthritis Rheum. 2014; 44: 253-263
        • Lapane K.L.
        • Sands M.R.
        • Yang S.
        • et al.
        Use of complementary and alternative medicine among patients with radiographic-confirmed knee osteoarthritis.
        Osteoarthritis Cartilage. 2012; 20: 22-28
        • Katz P.
        • Lee F.
        Racial/ethnic differences in the use of complementary and alternative medicine in patients with arthritis.
        J Clin Rheumatol. 2007; 13: 3-11
        • Carnes D.
        • Anwer Y.
        • Underwood M.
        • et al.
        Influences on older people’s decision making regarding choice of topical or oral NSAIDs for knee pain: qualitative study.
        Br Med J. 2008; 336: 142-145
        • Underwood M.
        • Ashby D.
        • Cross P.
        • et al.
        Advice to use topical or oral ibuprofen for chronic knee pain in older people: randomised controlled trial and patient preference study.
        Br Med J. 2008; 7636: 138-142
        • DeHaan M.N.
        • Guzman J.
        • Bayley M.T.
        • et al.
        Knee osteoarthritis clinical practice guidelines—how are we doing?.
        J Rheumatol. 2007; 34: 2099-2105
        • Hunter D.J.
        Lower extremity osteoarthritis management needs a paradigm shift.
        Br J Sports Med. 2011; 45: 283-288
        • Hunter D.J.
        Quality of osteoarthritis care for community-dwelling older adults.
        Clin Geriatr Med. 2010; 26: 401-417
        • Rosemann T.
        • Wensing M.
        • Joest K.
        • et al.
        Problems and needs for improving primary care of osteoarthritis patients: the views of patients, general practitioners and practice nurses.
        BMC Musculoskelet Disord. 2006; 7: 48
        • Chard J.
        • Dickson J.
        • Tallon D.
        • et al.
        A comparison of the views of rheumatologists, general practitioners and patients on the treatment of osteoarthritis.
        Rheumatology. 2002; 41: 1208-1210
        • Denoeud L.
        • Mazières B.
        • Payen-Champenois C.
        • et al.
        First line treatment of knee osteoarthritis in outpatients in France: adherence to the EULAR 2000 recommendations and factors influencing adherence.
        Ann Rheum Dis. 2005; 64: 70-74
        • Ganz D.A.
        • Chang J.T.
        • Roth C.P.
        • et al.
        Quality of osteoarthritis care for community-dwelling older adults.
        Arthritis Care Res. 2006; 55: 241-247